相关实验视频

Updated: Sep 14, 2025

An Ex Vivo Chicken Primary Bursal-cell Culture Model to Study Infectious Bursal Disease Virus Pathogenesis

An Ex Vivo Chicken Primary Bursal-cell Culture Model to Study Infectious Bursal Disease Virus Pathogenesis

Published on: October 4, 2018

在VP2中的Q221K突变驱动了传染病病毒的抗原转移

Haifeng Xiong^1,2,3, Jiayan Wu^1,2,3, Quan Xie^1,2,3,4

¹Key Laboratory of Jiangsu Preventive Veterinary Medicine, Key Laboratory for Avian Preventive Medicine, Ministry of Education, College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, China.

Frontiers in immunology

|July 25, 2025

概括

一个新型单克隆抗体在新出现的新型变种传染病病病毒 (nVarIBDV) 的 VP2 蛋白中确定了一个独特的抗原位点 (221K). 这一发现为对抗这种普遍存在的病原体的诊断和疫苗提供了新的目标.

科学领域:

兽医病毒学兽医病毒学
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

传染性病 (IBD) 是一种严重的免疫抑制性疾病,由传染性病病毒 (IBDV) 引起.
一种新的IBDV (nVarIBDV) 变种正在出现并迅速传播,显示出潜力逃避现有的疫苗免疫力.
了解nVarIBDV的独特抗原位点对于开发有效的控制策略至关重要.

研究的目的:

为了确定新出现的nVarIBDV菌株的独特抗原部位.
为了产生针对nVarIBDV.的单克隆抗体 (mAb).
调查已识别的抗原位点在免疫逃避中的作用.

主要方法:

作为免疫原体的nVarIBDV的VP2高变区 (VP2-HVR) 的表达.
对抗VP2.2的新型单克隆抗体 (mAb 5B5) 的生成和表征.
免疫光检测 (IFA),ELISA,表位图绘制,位点突变发生,中和检测和结构分析.

主要成果:

mAb 5B5特别识别了nVarIBDV及其VP2蛋白质,将其与经典的,非常毒性和减弱IBDV菌株区分开来.
在VP2蛋白中的221K残留物被确定为nVarIBDV菌株独有的关键,保存的抗原位点.
K221Q突变显著改变了IBDV血清的反应特征,mAb 5B5抑制了携带221K的工程IBDV的复制.

结论:

残留物221K代表了nVarIBDV VP2中的一个独特的抗原位点,有助于免疫逃逸.
这一发现为nVarIBDV抗原性提供了关键的见解.
已确定的221K地点为开发高效的诊断,疫苗和IBDV的分子监测提供了新的目标.

关键词:

221KK 在线观看在VP2中,VP2是VP2.抗原性是一种抗原性.不同化的差异化差异化.mAbAb 在线播放 nVarIBDVV 的时间.

更多相关视频

Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing

Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing

Published on: January 7, 2019

Author Spotlight: Exploring Cloning Techniques for Full-Length DNA Fragments

Author Spotlight: Exploring Cloning Techniques for Full-Length DNA Fragments

Published on: May 17, 2024

相关概念视频

Leaky Scanning

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Viral Recombination

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.